{"id":1664,"date":"2007-12-28T13:40:39","date_gmt":"2007-12-28T13:40:39","guid":{"rendered":"http:\/\/localhost:8888\/wordpress\/drug_manufacturer_called_to_ta\/"},"modified":"2024-12-17T16:10:00","modified_gmt":"2024-12-17T21:10:00","slug":"drug-manufacturer-called-to-ta","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/","title":{"rendered":"Drug Manufacturer Called To Task"},"content":{"rendered":"

Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last October when Genentech announced it was changing the distribution channels for Avastin, which would make it much more difficult for patients to receive the drug. Doctors accused the company of making the change to force the use of its more expensive drug, Lucentis.<\/p>\n

Lucentis is approved to treat macular degeneration, a condition that causes blindness and is encountered frequently in elderly patients. It costs approximately $2,000 per injection. Most patients require monthly injections.<\/p>\n

Many ophthalmologists have been Avastin, which is approved only to treat cancer, but works in the same way as Lucentis. Compounding pharmacies divide a vial of Avastin into small portions for use in the eye. In small doses, Avastin costs between $20 to $100 per injection.<\/p>\n

Continue reading<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last October when Genentech announced it was changing the distribution channels for Avastin, which would make it much more difficult for patients to receive the drug. Doctors accused the company of making the change […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[44],"class_list":["post-1664","post","type-post","status-publish","format-standard","hentry","category-personal-injury-wrongful-death","tag-personal-injury"],"yoast_head":"\nDrug Manufacturer Called To Task — Trial Attorney Blog — December 28, 2007<\/title>\n<meta name=\"description\" content=\"Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last — December 28, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Drug Manufacturer Called To Task — Trial Attorney Blog — December 28, 2007\" \/>\n<meta name=\"twitter:description\" content=\"Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last — December 28, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Finch McCranie, LLP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug Manufacturer Called To Task — Trial Attorney Blog — December 28, 2007","description":"Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last — December 28, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/","twitter_card":"summary_large_image","twitter_title":"Drug Manufacturer Called To Task — Trial Attorney Blog — December 28, 2007","twitter_description":"Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last — December 28, 2007","twitter_misc":{"Written by":"Finch McCranie, LLP","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/#article","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/"},"author":{"name":"Finch McCranie, LLP","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"headline":"Drug Manufacturer Called To Task","datePublished":"2007-12-28T13:40:39+00:00","dateModified":"2024-12-17T21:10:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/"},"wordCount":188,"keywords":["Personal Injury"],"articleSection":["Personal Injury & Wrongful Death"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/","url":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/","name":"Drug Manufacturer Called To Task — Trial Attorney Blog — December 28, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#website"},"datePublished":"2007-12-28T13:40:39+00:00","dateModified":"2024-12-17T21:10:00+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"description":"Drug manufacturer Genentech has been involved in a dispute with physicians over the use of its drug Avastin. Ophthalmologists became concerned last — December 28, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/blog\/drug-manufacturer-called-to-ta\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Drug Manufacturer Called To Task"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/blog\/#website","url":"https:\/\/www.finchmccranie.com\/blog\/","name":"Trial Attorney Blog","description":"Published by Georgia Trial Lawyers \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4","name":"Finch McCranie, LLP","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","caption":"Finch McCranie, LLP"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/comments?post=1664"}],"version-history":[{"count":1,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1664\/revisions"}],"predecessor-version":[{"id":33507,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1664\/revisions\/33507"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/media?parent=1664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/categories?post=1664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/tags?post=1664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}